Curreio
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.asserted
- Valid from
- 2021-04-05
- Valid until
- still holds
- Published
- 2021-04-04
- Recorded by AsOf
- 2026-11-14
- Checked
- 2026-11-14 · its source page states the value and the date, as read by an AI model
- Confidence
- 0.70
Sources
“TOKYO – April 5, 2021 – Curreio, Inc. (Curreio) and Preferred Networks, Inc. (PFN) announced today that the companies have started collaborative research for discovery of novel drug candidates using their deep learning and structural analysis technologies.”— what the page says, read 2026-11-14
Cite this claim
Plain text
AsOf. "Preferred Networks partnership: Curreio", as of 2021-04-05. Claim clm_16ACF812759A, https://asof.is/claim/clm_16ACF812759A, accessed 2026-11-14. Source: https://www.preferred.jp/en/news/pr20210405.
APA
AsOf. (2021). Preferred Networks partnership: Curreio (as of 2021-04-05) [Record clm_16ACF812759A]. Retrieved November 14, 2026, from https://asof.is/claim/clm_16ACF812759A (source: https://www.preferred.jp/en/news/pr20210405)
BibTeX
@misc{asof_clm_16ACF812759A,
author = {AsOf},
title = {Preferred Networks partnership: Curreio},
year = {2021},
howpublished = {\url{https://asof.is/claim/clm_16ACF812759A}},
note = {Claim clm\_16ACF812759A, as of 2021-04-05; source: https://www.preferred.jp/en/news/pr20210405},
urldate = {2026-11-14}
}On the record
/claim/clm_16ACF812759A.md/v1/claims/clm_16ACF812759Asubmit a correction